These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 27600491)

  • 1. Authentication and characterisation of a new oesophageal adenocarcinoma cell line: MFD-1.
    Garcia E; Hayden A; Birts C; Britton E; Cowie A; Pickard K; Mellone M; Choh C; Derouet M; Duriez P; Noble F; White MJ; Primrose JN; Strefford JC; Rose-Zerilli M; Thomas GJ; Ang Y; Sharrocks AD; Fitzgerald RC; Underwood TJ;
    Sci Rep; 2016 Sep; 6():32417. PubMed ID: 27600491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silencing microRNA-330-5p increases MMP1 expression and promotes an invasive phenotype in oesophageal adenocarcinoma.
    Bibby BAS; Miranda CS; Reynolds JV; Cawthorne CJ; Maher SG
    BMC Cancer; 2019 Aug; 19(1):784. PubMed ID: 31391080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of neuroepithelial transforming gene 1 is enhanced in oesophageal cancer and mediates an invasive tumour cell phenotype.
    Lahiff C; Cotter E; Casey R; Doran P; Pidgeon G; Reynolds J; Macmathuna P; Murray D
    J Exp Clin Cancer Res; 2013 Aug; 32(1):55. PubMed ID: 23945136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of distinct mutational patterns and new driver genes in oesophageal squamous cell carcinomas and adenocarcinomas.
    Lin DC; Dinh HQ; Xie JJ; Mayakonda A; Silva TC; Jiang YY; Ding LW; He JZ; Xu XE; Hao JJ; Wang MR; Li C; Xu LY; Li EM; Berman BP; Phillip Koeffler H
    Gut; 2018 Oct; 67(10):1769-1779. PubMed ID: 28860350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glutathione peroxidase 7 has potential tumour suppressor functions that are silenced by location-specific methylation in oesophageal adenocarcinoma.
    Peng D; Hu T; Soutto M; Belkhiri A; Zaika A; El-Rifai W
    Gut; 2014 Apr; 63(4):540-51. PubMed ID: 23580780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic analysis of HPV-positive versus HPV-negative oesophageal adenocarcinoma identifies a differential mutational landscape.
    Rajendra S; Wang B; Merrett N; Sharma P; Humphris J; Lee HC; Wu J
    J Med Genet; 2016 Apr; 53(4):227-31. PubMed ID: 26470716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of genomic alterations in oesophageal squamous cell cancer.
    Song Y; Li L; Ou Y; Gao Z; Li E; Li X; Zhang W; Wang J; Xu L; Zhou Y; Ma X; Liu L; Zhao Z; Huang X; Fan J; Dong L; Chen G; Ma L; Yang J; Chen L; He M; Li M; Zhuang X; Huang K; Qiu K; Yin G; Guo G; Feng Q; Chen P; Wu Z; Wu J; Ma L; Zhao J; Luo L; Fu M; Xu B; Chen B; Li Y; Tong T; Wang M; Liu Z; Lin D; Zhang X; Yang H; Wang J; Zhan Q
    Nature; 2014 May; 509(7498):91-5. PubMed ID: 24670651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MMP9 expression in oesophageal adenocarcinoma is upregulated with visceral obesity and is associated with poor tumour differentiation.
    Allott EH; Lysaght J; Cathcart MC; Donohoe CL; Cummins R; McGarrigle SA; Kay E; Reynolds JV; Pidgeon GP
    Mol Carcinog; 2013 Feb; 52(2):144-54. PubMed ID: 22121096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Open chromatin profiling identifies AP1 as a transcriptional regulator in oesophageal adenocarcinoma.
    Britton E; Rogerson C; Mehta S; Li Y; Li X; ; Fitzgerald RC; Ang YS; Sharrocks AD
    PLoS Genet; 2017 Aug; 13(8):e1006879. PubMed ID: 28859074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic catastrophes frequently arise in esophageal adenocarcinoma and drive tumorigenesis.
    Nones K; Waddell N; Wayte N; Patch AM; Bailey P; Newell F; Holmes O; Fink JL; Quinn MCJ; Tang YH; Lampe G; Quek K; Loffler KA; Manning S; Idrisoglu S; Miller D; Xu Q; Waddell N; Wilson PJ; Bruxner TJC; Christ AN; Harliwong I; Nourse C; Nourbakhsh E; Anderson M; Kazakoff S; Leonard C; Wood S; Simpson PT; Reid LE; Krause L; Hussey DJ; Watson DI; Lord RV; Nancarrow D; Phillips WA; Gotley D; Smithers BM; Whiteman DC; Hayward NK; Campbell PJ; Pearson JV; Grimmond SM; Barbour AP
    Nat Commun; 2014 Oct; 5():5224. PubMed ID: 25351503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumour expression of leptin is associated with chemotherapy resistance and therapy-independent prognosis in gastro-oesophageal adenocarcinomas.
    Bain GH; Collie-Duguid E; Murray GI; Gilbert FJ; Denison A; McKiddie F; Ahearn T; Fleming I; Leeds J; Phull P; Park K; Nanthakumaran S; Matula KM; Grabsch HI; Tan P; Welch A; Schweiger L; Dahle-Smith A; Urquhart G; Finegan M; Petty RD
    Br J Cancer; 2014 Mar; 110(6):1525-34. PubMed ID: 24569475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular pathways in the development and treatment of oesophageal cancer.
    Walker RC; Underwood TJ
    Best Pract Res Clin Gastroenterol; 2018; 36-37():9-15. PubMed ID: 30551862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic value of TP53 mutations in oesophageal adenocarcinoma: a systematic review and meta-analysis.
    Fisher OM; Lord SJ; Falkenback D; Clemons NJ; Eslick GD; Lord RV
    Gut; 2017 Mar; 66(3):399-410. PubMed ID: 26733670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mobile element insertions are frequent in oesophageal adenocarcinomas and can mislead paired-end sequencing analysis.
    Paterson AL; Weaver JM; Eldridge MD; Tavaré S; Fitzgerald RC; Edwards PA;
    BMC Genomics; 2015 Jul; 16(1):473. PubMed ID: 26159513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-free tumour DNA analysis detects copy number alterations in gastro-oesophageal cancer patients.
    Wallander K; Eisfeldt J; Lindblad M; Nilsson D; Billiau K; Foroughi H; Nordenskjöld M; Liedén A; Tham E
    PLoS One; 2021; 16(2):e0245488. PubMed ID: 33539436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subtypes of Barrett's oesophagus and oesophageal adenocarcinoma based on genome-wide methylation analysis.
    Yu M; Maden SK; Stachler M; Kaz AM; Ayers J; Guo Y; Carter KT; Willbanks A; Heinzerling TJ; O'Leary RM; Xu X; Bass A; Chandar AK; Chak A; Elliott R; Willis JE; Markowitz SD; Grady WM
    Gut; 2019 Mar; 68(3):389-399. PubMed ID: 29884612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibroblasts derived from oesophageal adenocarcinoma differ in DNA methylation profile from normal oesophageal fibroblasts.
    Smith E; Palethorpe HM; Hayden AL; Young JP; Underwood TJ; Drew PA
    Sci Rep; 2017 Jun; 7(1):3368. PubMed ID: 28611465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel metastatic models of esophageal adenocarcinoma derived from FLO-1 cells highlight the importance of E-cadherin in cancer metastasis.
    Liu DS; Hoefnagel SJ; Fisher OM; Krishnadath KK; Montgomery KG; Busuttil RA; Colebatch AJ; Read M; Duong CP; Phillips WA; Clemons NJ
    Oncotarget; 2016 Dec; 7(50):83342-83358. PubMed ID: 27863424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrative analysis of array-comparative genomic hybridisation and matched gene expression profiling data reveals novel genes with prognostic significance in oesophageal adenocarcinoma.
    Goh XY; Rees JR; Paterson AL; Chin SF; Marioni JC; Save V; O'Donovan M; Eijk PP; Alderson D; Ylstra B; Caldas C; Fitzgerald RC
    Gut; 2011 Oct; 60(10):1317-26. PubMed ID: 21478220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered mitochondrial function and energy metabolism is associated with a radioresistant phenotype in oesophageal adenocarcinoma.
    Lynam-Lennon N; Maher SG; Maguire A; Phelan J; Muldoon C; Reynolds JV; O'Sullivan J
    PLoS One; 2014; 9(6):e100738. PubMed ID: 24968221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.